x
Filter:
Filters applied
- IASLC Staging Articles
- Ruffini, EnricoRemove Ruffini, Enrico filter
- StagingRemove Staging filter
- MesotheliomaRemove Mesothelioma filter
Author
- Rusch, Valerie W2
- van Meerbeeck, Jan P2
- Asamura, Hisao1
- Cangir, Ayten K1
- Chansky, Kari1
- Edwards, John1
- Galateau-Sallé, Françoise1
- Giroux, Dorothy1
- Hoffmann, Hans1
- Kennedy, Catherine1
- Kindler, Hedy L1
- McCaughan, Brian C1
- Nakano, Takashi1
- Nowak, Anna1
- Nowak, Anna K1
- Pass, Harvey1
- Pass, Harvey I1
- Rice, David1
- Rice, David C1
- Shemanski, Lynn1
- Waller, David1
- Weder, Walter1
- Yoshimura, Masahiro1
IASLC Staging Articles
2 Results
- Original Article IASLC Staging Committee ArticleOpen Archive
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Journal of Thoracic OncologyVol. 11Issue 12p2112–2119Published online: September 26, 2016- Valerie W. Rusch
- Kari Chansky
- Hedy L. Kindler
- Anna K. Nowak
- Harvey I. Pass
- David C. Rice
- and others
Cited in Scopus: 133The M component and TNM stage groupings for malignant pleural mesothelioma (MPM) have been empirical. The International Association for the Study of Lung Cancer developed a multinational database to propose evidence-based revisions for the eighth edition of the TNM classification of MPM. - Original Article IASLC Staging Committee ArticleOpen Archive
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
Journal of Thoracic OncologyVol. 11Issue 12p2082–2088Published online: September 23, 2016- Harvey Pass
- Dorothy Giroux
- Catherine Kennedy
- Enrico Ruffini
- Ayten K. Cangir
- David Rice
- and others
Cited in Scopus: 48For nearly 40 years, there was no generally accepted staging system for malignant pleural mesothelioma. In 1994, members of the International Mesothelioma Interest Group, in collaboration with the International Association for the Study of Lung Cancer, proposed a TNM staging system based on analyses of outcomes in retrospective surgical series and small clinical trials. Subsequently accepted by the American Joint Commission on Cancer and the Union for International Cancer Control for the sixth editions of their staging manuals, this system has since been the international staging standard.